Plus de 1 500 auteurs et chercheurs provenant de plus de 27 pays
David L. Entin
David Entin wrote this case study as Business Development Director at EntreMed Inc. He is now Director, Corporate Contracts, Licensing and Business Development at GlycoMimetics.
